NFAT3 and TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis

Abstract

Insights

Researchers uncovered a novel regulatory mechanism for microRNA-140 (miR-140) in osteoarthritis (OA) chondrocytes, independent of the WWP2 gene. This finding reveals new roles for NFAT3 and SMAD3 in OA pathogenesis and miR-140 transcription, potentially advancing OA therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) regulate gene expression, with miR-140 found in the WWP2 gene.
  • miR-140 targets genes detrimental to osteoarthritis (OA), but its expression is reduced in OA chondrocytes.
  • Investigated the regulation of miR-140 in human OA chondrocytes due to decreased expression.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of miR-140 in human OA chondrocytes.
  • To identify factors influencing miR-140 expression independent of WWP2.
  • To explore the roles of NFAT3 and SMAD3 in miR-140 regulation within the context of OA.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) for gene expression analysis.
  • Small interfering RNA (siRNA) for gene silencing in OA chondrocytes.
  • Chromatin immunoprecipitation (ChIP) and mutagenesis to identify regulatory binding sites on rsmiR-140.
  • Immunocytochemistry to assess protein translocation.

Main Results:

  • WWP2 expression was similar in normal and OA cells, indicating miR-140 regulation independent of WWP2.
  • NFAT3 and SMAD3 were identified as direct regulators of miR-140 transcription, acting as an activator and repressor, respectively.
  • Transforming growth factor-beta (TGF-β) interfered with NFAT3 translocation, subsequently impacting miR-140 expression.

Conclusions:

  • This study presents the first evidence of miR-140 regulation independent of WWP2.
  • Identified distinct roles for NFAT3 and SMAD3 in regulating miR-140 transcription during OA.
  • Findings offer potential for novel therapeutic strategies targeting OA by modulating miR-140 regulatory pathways.